These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38498999)

  • 1. The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment.
    Dominoni M; Barcellini A; Pasquali MF; De Silvestri A; Ferretti VV; Cesari S; Fiandrino G; Orlandi E; Gardella B
    Gynecol Obstet Invest; 2024; 89(4):295-303. PubMed ID: 38498999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia.
    Origoni M; Cantatore F; Candotti G; Candiani M
    Biomed Res Int; 2022; 2022():1149789. PubMed ID: 35445135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence.
    Farzaneh F; Faghih N; Hosseini MS; Arab M; Ashrafganjoei T; Bahman A
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2365-2372. PubMed ID: 31450907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated neutrophil-lymphocyte ratio can be a biomarker for predicting the development of cervical intraepithelial neoplasia.
    Xu L; Song J
    Medicine (Baltimore); 2021 Jul; 100(28):e26335. PubMed ID: 34260524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization.
    Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
    Kang WD; Kim SM
    Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure.
    Cecchini S; Carozzi F; Confortini M; Zappa M; Ciatto S
    Tumori; 2004; 90(2):225-8. PubMed ID: 15237586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
    Sarkar AK; Tortolero-Luna G; Follen M; Sastry KJ
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S251-61. PubMed ID: 16188303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
    Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
    Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
    Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
    J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
    Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
    Huang HJ; Tung HJ; Yang LY; Chao A; Tang YH; Chou HH; Chang WY; Wu RC; Huang CC; Lin CY; Liao MJ; Chen WC; Lin CT; Chen MY; Huang KG; Wang CJ; Chang TC; Lai CH
    Int J Cancer; 2021 Feb; 148(3):665-672. PubMed ID: 32781482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
    Kreimer AR; Schiffman M; Herrero R; Hildesheim A; González P; Burk RD; Porras C; Sherman ME; Demuth F; Cheung L; Bratti C; Cecilia Rodríguez A
    Int J Cancer; 2012 Jul; 131(1):211-8. PubMed ID: 21823117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative approach to preneoplastic cervical lesions in postmenopause.
    Vetrano G; Aleandri V; Ciolli P; Scardamaglia P; Pacchiarotti A; Verrico M; Carboni S; Corosu R
    Anticancer Res; 2008; 28(6B):3941-4. PubMed ID: 19192654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.